File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.vaccine.2007.10.043
- Scopus: eid_2-s2.0-36749085269
- PMID: 18037542
- WOS: WOS:000252490700001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: "All that palsies is not Bell's [1]"-The need to define Bell's palsy as an adverse event following immunization
Title | "All that palsies is not Bell's [1]"-The need to define Bell's palsy as an adverse event following immunization |
---|---|
Authors | |
Keywords | AEFI Bell's palsy Clinical definition |
Issue Date | 2007 |
Publisher | Elsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/vaccine |
Citation | Vaccine, 2007, v. 26 n. 1, p. 1-14 How to Cite? |
Abstract | Bell's palsy has been reported as an adverse event following immunization (AEFI). Review of the published literature reveals that several characteristics have been used to describe Bell's palsy, which differ significantly from author to author. Evidently, the definition of "Bell's palsy" remains controversial, and consensus between different medical subspecialties is urgently needed. The Brighton Collaboration has formed an international working group with representatives of neurology, otorhinolaryngology, pediatrics, electrophysiology, pharmacology, pharmaceutical and biotech industry as well as regulatory agencies to create a case definition of Bell's palsy as an AEFI. © 2007 Elsevier Ltd. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/143514 |
ISSN | 2023 Impact Factor: 4.5 2023 SCImago Journal Rankings: 1.342 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rath, B | en_HK |
dc.contributor.author | Linder, T | en_HK |
dc.contributor.author | Cornblath, D | en_HK |
dc.contributor.author | Hudson, M | en_HK |
dc.contributor.author | Fernandopulle, R | en_HK |
dc.contributor.author | Hartmann, K | en_HK |
dc.contributor.author | Heininger, U | en_HK |
dc.contributor.author | Izurieta, H | en_HK |
dc.contributor.author | Killion, L | en_HK |
dc.contributor.author | Kokotis, P | en_HK |
dc.contributor.author | Oleske, J | en_HK |
dc.contributor.author | Vajdy, M | en_HK |
dc.contributor.author | Wong, V | en_HK |
dc.date.accessioned | 2011-12-12T03:51:24Z | - |
dc.date.available | 2011-12-12T03:51:24Z | - |
dc.date.issued | 2007 | en_HK |
dc.identifier.citation | Vaccine, 2007, v. 26 n. 1, p. 1-14 | en_HK |
dc.identifier.issn | 0264-410X | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/143514 | - |
dc.description.abstract | Bell's palsy has been reported as an adverse event following immunization (AEFI). Review of the published literature reveals that several characteristics have been used to describe Bell's palsy, which differ significantly from author to author. Evidently, the definition of "Bell's palsy" remains controversial, and consensus between different medical subspecialties is urgently needed. The Brighton Collaboration has formed an international working group with representatives of neurology, otorhinolaryngology, pediatrics, electrophysiology, pharmacology, pharmaceutical and biotech industry as well as regulatory agencies to create a case definition of Bell's palsy as an AEFI. © 2007 Elsevier Ltd. All rights reserved. | en_HK |
dc.language | eng | en_US |
dc.publisher | Elsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/vaccine | en_HK |
dc.relation.ispartof | Vaccine | en_HK |
dc.subject | AEFI | en_HK |
dc.subject | Bell's palsy | en_HK |
dc.subject | Clinical definition | en_HK |
dc.subject.mesh | Action Potentials | en_US |
dc.subject.mesh | Bell Palsy/diagnosis/*etiology/virology | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Immunization/*adverse effects | en_US |
dc.subject.mesh | Magnetic Resonance Imaging | en_US |
dc.title | "All that palsies is not Bell's [1]"-The need to define Bell's palsy as an adverse event following immunization | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Wong, V:vcnwong@hku.hk | en_HK |
dc.identifier.authority | Wong, V=rp00334 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.vaccine.2007.10.043 | en_HK |
dc.identifier.pmid | 18037542 | - |
dc.identifier.scopus | eid_2-s2.0-36749085269 | en_HK |
dc.identifier.hkuros | 140616 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-36749085269&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 26 | en_HK |
dc.identifier.issue | 1 | en_HK |
dc.identifier.spage | 1 | en_HK |
dc.identifier.epage | 14 | en_HK |
dc.identifier.isi | WOS:000252490700001 | - |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | Rath, B=23028714000 | en_HK |
dc.identifier.scopusauthorid | Linder, T=7006782008 | en_HK |
dc.identifier.scopusauthorid | Cornblath, D=7006050597 | en_HK |
dc.identifier.scopusauthorid | Hudson, M=35955887900 | en_HK |
dc.identifier.scopusauthorid | Fernandopulle, R=6505964605 | en_HK |
dc.identifier.scopusauthorid | Hartmann, K=7201407355 | en_HK |
dc.identifier.scopusauthorid | Heininger, U=7004342891 | en_HK |
dc.identifier.scopusauthorid | Izurieta, H=6701411998 | en_HK |
dc.identifier.scopusauthorid | Killion, L=35082158800 | en_HK |
dc.identifier.scopusauthorid | Kokotis, P=6508237886 | en_HK |
dc.identifier.scopusauthorid | Oleske, J=7005734322 | en_HK |
dc.identifier.scopusauthorid | Vajdy, M=6701840955 | en_HK |
dc.identifier.scopusauthorid | Wong, V=7202525632 | en_HK |
dc.identifier.issnl | 0264-410X | - |